Have you ever wondered how hospital emergency departments (EDs) got their name when a large majority of the people who visit them are not experiencing an emergency? Should they be called something else, or should they finally serve only those patients with emergencies? These are interesting thoughts and questions; the answers are not easily surmised.
In his latest blog post, Vizient Research Institute executive director Tom Robertson urges caution when contemplating the merits of additional provider consolidation stemming from the economic impacts of the global crisis. The mere prospect of all payer rate regulation somewhere down the road — hardly a certainty but extraordinarily disruptive were it to occur — makes applying traditional revenue and pricing assumptions to a new normal future increasingly tenuous.
From cost-saving initiatives and quality enhancements to the introduction of new technology that will drive procedural efficiencies, there are many reasons for supply chain leaders to introduce new products to clinicians. But how new products are presented can make or break clinician acceptance.
Clinical-supply integration (CSI) has become a recognizable concept for many health care organizations as they continue to focus on performance improvement. But many are unsure how to operationalize a CSI model that fits their organization.
John D. Rockefeller oncesaid, “Don’t be afraid to give up the good to go for the great.” It’s hard to argue with Rockefeller’s successful approach to business. To apply his philosophy in supply chain, we need to rethink our approach to product decision-making.
Traditional value analysis committees have been making decisions on the purchase of clinical products and services for years. Typically residing in the supply chain department, these value analysis programs have not always been efficient.
For years, health care supply chain professionals have been charged with balancing cost, quality and clinician preference when introducing new products and technologies to the organization. We often refer to this process as value analysis work and, more recently, it’s been referred to as clinical-supply integration. Is there really a difference between the two concepts?
Sound sleep is an imperative in achieving and maintaining good health. Yet, according to the National Sleep Foundation, between 50 and 70 million Americans experience some sort of sleep or wakefulness disorder. Because of these statistics, sleep medicine is a growing specialty area and in high demand.
In addition to caring for critically ill patients, caregivers and support staff are battling changes to workload, shortages in necessary PPE and concern for the safety of their own families; all leaving them vulnerable to extreme stress.
This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.